Title: Response to Comment on Umpierrez and Klonoff. Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital. Diabetes Care 2018;41:1579–1589
Abstract: We appreciate the comments of Delgado-Hurtado et al. (1) regarding our article (2) and the safety of MRI and CT in patients wearing insulin pumps.
The U.S. Food and Drug Administration (FDA) has reported serious adverse events, including patient injury and death, associated with the use of implantable infusion pumps in the magnetic resonance environment (3). Reported adverse events included medication dosing inaccuracies, including overinfusion or underinfusion or unintended bolus, and mechanical problems. Thus, it is recommended to remove insulin pumps during MRI procedures.
Delgado-Hurtado et al. (1) questioned the amount …